期刊文献+

氨基胍和维生素C对糖尿病大鼠肾功能的保护作用

Protective Effect of Aminoguanidine and Vitamin C on Renal Function of Streptozotocin-Induced Diabetic Rats
下载PDF
导出
摘要 目的观察氨基胍、维生素C对糖尿病大鼠肾脏的保护作用。方法利用链脲佐菌素腹腔注射法诱导建立Ⅰ型糖尿病大鼠模型,将实验用SD大鼠随机分为正常对照组、糖尿病组、氨基胍治疗组、维生素C治疗组、维生素C和氨基胍联合治疗组。治疗16周。观察治疗期间及治疗后大鼠的一般状况、血糖、尿素氮、血肌酐,内生肌酐清除率、24h尿蛋白排泄率。结果①造模组大鼠均出现肾脏功能损害;②氨基胍、维生素C对血糖无影响,但能改善基本状况,降低糖尿病大鼠的尿素氮、血肌酐、24h尿白蛋白排泄率,增加内生肌酐清除率;③两种药物联合用药具有协同作用。结论氨基胍、维生素C无降糖作用,但具有确切的肾脏保护作用,联合用药有协同作用。 Objective To observe the effect of aminoguanidine and vitamin C on renal function of streptozotocin- indiabetic rats. Methods Diabetic nephropathy rat models were induced by intraperitoneal injection of streptozotocin (STZ). Rats were allocated to normal control group, model group, vitamin C group, aminoguanidine group, and vitamin C and arninoguanidine combined group and received the treatment for a 16 - week period. During and after the treatment, the general status, blood glucose levels, blood urea nitrogen, serum creatinine, urinary albumin excretion rate within 24 - hour, and clearance rate of creatinine were monitored. Results Diabetes rnellitus and renal function lesion occurred in all the four DM model groups. Aminoguanidine and vitamin C had no effect on the blood glucose levels, but improved the general status, decreased blood urea nitrogen, serum creatinine, and urinary albumin excretion; increased creatinine clearance. Combined both arninoguanidine and vitamin C shewed a synergic action. Conclusion Aminoguanidine and vitamin C do not affect hyperglycemia but protect the renal function of model animals; and combination of both drugs demonstrates synergic activity.
出处 《实用预防医学》 CAS 2006年第3期557-559,共3页 Practical Preventive Medicine
关键词 氨基胍 维生素C 糖尿病模型 肾功能 Aminoguanidine Vitamin C Diabetic models Renal function
  • 相关文献

参考文献9

  • 1Bayne JW.Role of oxidative stress in development of complications in diabetes[J].Diabetes,1991,40:405-412.
  • 2Makita Z,Yanagisawa K,Kuwajima S,et al,Advanced glycation end products and diabetic nephropathy[J].J Diabetes Complications,1995,9:265-268.
  • 3John WB.Role of oxidative stress in development of complications in diabetes[J].Diabetes,1992,40:405.
  • 4TominoY,Wang LN,Fukui M,et al.Glomerular nonenzymatic glycosylation and liqid peroxide are increased in the early phase of streptozotocin induced diabetic rats prior to major hisopathologic alteration[J].Nephron,1991,59:632.
  • 5Tilton RG,Chang K,Allison W,et al.Glycosylation induced increases in blood flow and 125I-albamn permeation:role of nitric oxide and superoxide(abstract)[J].FASEB,1993,7 (part Ⅱ):A905.
  • 6Jain SK,Palmer M,.The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins[J].Free Radical Biol Med,1997,22:593-596.
  • 7Parving HH,Osterby M,Ritz E.Diabetic nephropathy.In:The kidney.Brenner BM ed[M].Philadelphia:WB Saunder Company,2000.1731-1754.
  • 8Figarola JL,Scott S.Loera S,Tessler C.LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats[J].Diabetologia,2003,46 (8):1140-1152.
  • 9Raven PA,De Rubertis FR,Kagan VE,et al.Effects ofsupple mentation with vitamin C or E on albuminuria,glomerular TGF-1,and glomerular size in diabetes[J].J Am Soc Nepheol,1997,8:1405-1411.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部